Answers are grounded in this paper and cite their sources.
This economic evaluation estimates insulin savings that would result if Medicare Part D used US Department of Veterans Affairs–negotiated prices and the Veterans Affairs formulary for patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Feldman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: